SOUTH SAN FRANCISCO, Calif., Nov. 10, 2023 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. ("UNITY" or the "Company") [Nasdaq: UBX], a biotechnology company developing therapeutics to slow, halt, or ...
CINCINNATI, Aug. 01, 2023 (GLOBE NEWSWIRE) -- Blue Water Biotech, Inc. ("Blue Water" or the "Company") (Nasdaq: BWV), today announced it has entered into a definitive agreement for the exercise of ...
Japan’ Nxera Pharma today announces that it has exercised its option to license lucerastat from Idorsia and has entered into ...
October 15, 2026, with an exercise price set at $0.3701 per share. Option quantity: 250,000 stock options representing the right to purchase 250,000 sh ...
UNITY Biotechnology, Inc. (“UNITY” or the “Company”) [Nasdaq: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today announced the entry into a ...
Biotech Bullfrog AI (NASDAQ:BFRG) has added an exercise price for warrants to be offered through a proposed $8M initial public offering. The AI-based drug developer said in a filing that it still ...
REHOVOT, Israel, July 01, 2024 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. (“Purple Biotech” or “the Company”) (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class therapies that seek ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results